AU7421598A - Methods of enhancing functioning of the large intestine - Google Patents

Methods of enhancing functioning of the large intestine

Info

Publication number
AU7421598A
AU7421598A AU74215/98A AU7421598A AU7421598A AU 7421598 A AU7421598 A AU 7421598A AU 74215/98 A AU74215/98 A AU 74215/98A AU 7421598 A AU7421598 A AU 7421598A AU 7421598 A AU7421598 A AU 7421598A
Authority
AU
Australia
Prior art keywords
methods
large intestine
functioning
enhancing
enhancing functioning
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74215/98A
Inventor
Daniel J. Drucker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
1149336 Ontario Inc
Original Assignee
1149336 Ontario Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 1149336 Ontario Inc filed Critical 1149336 Ontario Inc
Publication of AU7421598A publication Critical patent/AU7421598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
AU74215/98A 1998-05-11 1998-05-11 Methods of enhancing functioning of the large intestine Abandoned AU7421598A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA1998/000477 WO1999058144A1 (en) 1998-05-11 1998-05-11 Methods of enhancing functioning of the large intestine

Publications (1)

Publication Number Publication Date
AU7421598A true AU7421598A (en) 1999-11-29

Family

ID=4173297

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74215/98A Abandoned AU7421598A (en) 1998-05-11 1998-05-11 Methods of enhancing functioning of the large intestine

Country Status (2)

Country Link
AU (1) AU7421598A (en)
WO (1) WO1999058144A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2236519C (en) 1997-05-02 2011-09-13 1149336 Ontario Inc. Methods of enhancing functioning of the large intestine
ES2310192T3 (en) 2000-09-18 2009-01-01 Sanos Bioscience A/S USE OF GLP-2 PEPTIDES.
US7371721B2 (en) 2000-09-18 2008-05-13 Sanos Bioscience A/S Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes
US7411039B2 (en) 2002-10-14 2008-08-12 Novo Nordisk A/S GLP-2 compounds, formulations, and uses thereof
NZ597554A (en) 2006-11-08 2014-04-30 Zealand Pharma As Selective glucagon-like-peptide-2 (glp-2) analogues
AU2013255752B2 (en) 2012-05-03 2017-11-09 Zealand Pharma A/S Glucagon-like-peptide-2 (GLP-2) analogues
CA3043151A1 (en) 2016-12-09 2018-06-14 Zealand Pharma A/S Acylated glp-1/glp-2 dual agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997039031A1 (en) * 1996-04-12 1997-10-23 1149336 Ontario Inc. Glucagon-like peptide-2 analogs
US5952301A (en) * 1996-12-10 1999-09-14 1149336 Ontario Inc. Compositions and methods for enhancing intestinal function

Also Published As

Publication number Publication date
WO1999058144A1 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
AU3485999A (en) Neo-tryptophan
AU9392998A (en) Pack-a-pillow
AU3522399A (en) Carvedilol-galenics
AU3437799A (en) City-car
AU3253699A (en) Myxochelines
AU5407599A (en) Sphingolipid-desaturase
AU7421598A (en) Methods of enhancing functioning of the large intestine
AU8363398A (en) Capotasto
AU2609599A (en) Sensor-coupling
AU2227999A (en) Human ependymin
AU3204999A (en) Futureball
AU2069199A (en) Codelets
AU1055399A (en) Rollerboard
AU2202100A (en) Human brainiac-5
AU9347498A (en) Imidazotriazolopyrimidines
AU3347599A (en) Aeromobile
AU5223199A (en) Bathtub-bathseat
AU3819799A (en) Methoximinomethyloxathiazines
AU2840799A (en) 1-phosphanorbornadienes
EP0992489B8 (en) Betaines
AU9218098A (en) Exocyclic-phosphoethanolamines
AU1779099A (en) Heterocyclyl-derivatives
AU4768799A (en) Bookcover
AUPP412198A0 (en) Methods
AUPP410198A0 (en) Methods

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase